Dbv Technologies

Bionet-asia, Co. Ltd.

Lucie Mondoulet

Pierre-Henri Benhamou

Bertrand Dupont

Christophe Dupont

Nathalie Donne

Pierre-louis Herve

Hong Thai Pham

Vincent Dioszeghy

The present invention relates to improved epicutaneous administration methods for vaccination of a subject. In particular, the present invention discloses the use of an antigen for epicutaneous immunization, wherein the antigen is administered by epicutaneous application with a skin patch device in combination with an epidermal skin treatment.

Optimized epicutaneous vaccination

The present invention relates to the treatment of EE. More specifically, the invention relates to a new method of treating EE through the epicutaneous route. In particular, the method of the invention comprises applying to the skin of the subject a skin patch device, comprising a composition, under conditions allowing a contact between said composition and the skin. The present invention also relates to the skin patch device and to a use of the skin patch device in the manufacture of a composition for treating eosinophilic esophagitis in a subject.

Method of treating eosinophilic esophagitis

The present invention describes a new method for progressive desensitization of a subject to groundnut. More specifically, the invention relates to the immunotherapeutic method for increasing groundnut tolerance in an allergic subject using epicutaneous administration. The present invention is also relative to the use of a skin patch device for progressive desensitization of a subject to groundnut.

Immunotherapeutic method for increasing groundnut tolerance in a subject

Growing community of inventors

Chatillon, France

Lucie Mondoulet